Mechanism-based inhibition of CYP3A4 and CYP2D6 by Indonesian medicinal plants

被引:33
|
作者
Subehan
Usia, Tepy
Iwata, Hiroshi
Kadota, Shigetoshi
Tezuka, Yasuhiro
机构
[1] Toyama Med & Pharmaceut Univ, Inst Nat Med, Toyama 9300194, Japan
[2] Mitsubishi Chem Safety Inst Ltd, Tokyo 3140255, Japan
[3] Toyama Med & Pharmaceut Univ, Cent COE Program 21, Toyama 9300194, Japan
关键词
Indonesian medicinal plants; mechanism-based inhibition; cytochrome P450; CYP3A4; CYP2D6;
D O I
10.1016/j.jep.2005.12.001
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Thirty samples of Indonesian medicinal plants were tested for their mechanism-based inhibition on cytochrome P450 3A4 (CYP3A4) and CYP2D6 via erythromycin N-demethylation and dextromethorphan O-demethylation activities in human liver microsomes. From screening with 0 and 20 min preincubation at 0.5 mg/ml of methanol extracts, five plants (Cinnamomum burmani bark, Foeniculum vulgare seed, Strychnos ligustrina wood, Tinospora crispa stem, and Zingiber cassumunar rhizome) showed more than 30% increase of CYP3A4 inhibition, while three (Alpinia galanga rhizome, Melaleuca leucadendron leaf, and Piper nigrum fruit) showed more than 30% increase of CYP2D6 inhibition. In these eight plants, Foeniculum vulgare seed, Cinnamomum burmani bark, and Strychnos ligustrina wood showed time-dependent inhibition on CYP3A4 and Piper nigrum fruit and Melaleuca leucadendron leaf on CYP2D6. Among these, four plants other than Melaleuca leucadendron revealed NADPH-dependent inhibition. Thus, Foeniculum vulgare, Cinnamomunt burmani, and Strychnos ligustrina should contain mechanism-based inhibitors on CYP3A4 and Piper nigrum contain that on CYP2D6. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:449 / 455
页数:7
相关论文
共 50 条
  • [41] Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by grapefruit juice and proadifen.
    Adigun, AQ
    Jones, DR
    Hall, SD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P61 - P61
  • [42] Aloe Vera Juice: IC50 and Dual Mechanistic Inhibition of CYP3A4 and CYP2D6
    Djuv, Ane
    Nilsen, Odd Georg
    PHYTOTHERAPY RESEARCH, 2012, 26 (03) : 445 - 451
  • [43] Comparison of metasite and stardrop prediction of CYP3A4, CYP2C9 and CYP2D6
    Gopaul, V. Sashi
    Shin, Young
    Le, Hoa
    Baumgardner, Matthew
    Hop, Cornelis
    Khojasteh, Cyrus
    DRUG METABOLISM REVIEWS, 2009, 41 : 119 - 119
  • [44] Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6
    Pandit, Subrata
    Mukherjee, Pulok K.
    Ponnusankar, Sivasankaran
    Venkatesh, Murugan
    Srikanth, N.
    FITOTERAPIA, 2011, 82 (03) : 369 - 374
  • [45] CHRONIC MODULATION OF CYP2D6 AND CYP3A4 ACTIVITIES BY QUINIDINE AND RIFAMPICIN RESPECTIVELY
    ADEDOYIN, A
    MAURO, K
    KUBISTY, C
    BOYER, A
    PORTER, J
    BRANCH, RA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 210 - 210
  • [46] Modulation of CYP2D6 and CYP3A4 metabolic activities by Ferula asafetida resin
    Al-Jenoobi, Fahad I.
    Al-Thukair, Areej A.
    Alam, Mohd Aftab
    Abbas, Fawkeya A.
    Al-Mohizea, Abdullah M.
    Alkharfy, Khalid M.
    Al-Suwayeh, Saleh A.
    SAUDI PHARMACEUTICAL JOURNAL, 2014, 22 (06) : 564 - 569
  • [47] The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
    Loos, Nancy H. C.
    Beijnen, Jos H.
    Schinkel, Alfred H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [48] Development and Validation of HPLC Methods for the Determination of CYP2D6 and CYP3A4 Activities
    Pan, Yan
    Mak, Joon Wah
    Ong, Chin Eng
    CURRENT PHARMACEUTICAL ANALYSIS, 2012, 8 (03) : 219 - 224
  • [49] Probabilistic prediction of the human CYP3A4 and CYP2D6 metabolism sites in a molecule
    Dapkunas, Justas
    Sazonovas, Andrius
    Japertas, Pranas
    TOXICOLOGY LETTERS, 2008, 180 : S94 - S94
  • [50] Sugar-mediated lyoprotection of purified human CYP3A4 and CYP2D6
    Chefson, Amandine
    Zhao, Jin
    Auclair, Karine
    JOURNAL OF BIOTECHNOLOGY, 2007, 130 (04) : 436 - 440